Author: Leslie Toldo
The McLaren Proton Therapy Center is pleased to welcome board-certified Radiation Oncologist Hani Al Halabi. He joins a comprehensive team of oncologists at McLaren Flint who work closely to offer patients their best chance at fighting cancer.
“I am a passionate physician, and I love what I do,” Dr. Al Halabi said. “I am an advocate for my patients and always strive to deliver the best care I can. To me that comes down to the quality of the treatment my patients will receive, and at McLaren I have the tools and support to achieve that.”
Dr. Al Halabi received his doctoral degree in medicine from McGill University in Montreal, Canada. He completed his radiation oncology residency at McGill University, then went on to pursue a clinical fellowship in proton therapy at the Massachusetts General Hospital, Harvard School of Medicine in Boston.
Protons deliver targeted radiation to tumors, more precisely than traditional photon beams. Protons stop at the tumor, while photons, or X-rays, continue beyond the tumor, leaving behind an exit dose of radiation that can damage healthy tissue and organs near the tumor. For patients, this means fewer short- and long-term side effects with protons, versus traditional radiation therapy.
Dr. Al Halabi will treat patients with conventional radiation at the Karmanos Cancer Institute at McLaren Flint and proton patients at the adjoining McLaren Proton Therapy Center. Recently diagnosed cancer patients, or those seeking second opinions, may call (855) MY-PROTON (855-697-7686) or visit mclaren.org/protontherapy.